Curie: Healthcare in Focus

Curie: Healthcare in Focus

by Curie

Medicine News Commentary

Season 1

Jonas Salk, 70 Years On

Seventy years ago, Jonas Salk changed history with the first successful polio vaccine—an innovation that reshaped public health and saved millions of lives. But what does his legacy mean in a world now grappling with vaccine skepticism, science politicization, and resurging preventable diseases? In this episode of Curie, we reflect on Salk’s radical generosity, the ethics of scientific discovery, and what today’s healthcare professionals can still learn from his example.

AACR 2025 Preview: Trials to Watch, Targets to Track, and Technologies That Could Change Oncology

In this Curie episode, Matt previews what’s coming at AACR 2025, happening April 25–30 in Chicago. Get ready for a data-packed week with practice-changing trials like KEYNOTE-689 and Beamion LUNG-1, along with fresh momentum in AI-powered oncology, cancer interception, and new modalities like peptide drug conjugates and RNA-targeting agents. From early detection to trial equity, this preview outlines the trends and themes every oncologist should be watching ahead of the meeting.

Can a Vaccine Cure Cancer?

A cancer vaccine? It’s not science fiction anymore. In this episode of Curie, host Andrew unpacks a groundbreaking personalized vaccine trial led by Dr. Vinod Balachandran at Memorial Sloan Kettering. By training the immune system to recognize mutations unique to each patient’s tumor, this approach is rewriting the rules of cancer care. We explore how mRNA, long known for its role in COVID vaccines, could become the blueprint for a new era in oncology—one that’s personal, programmable, and potentially transformative.

AAN 2025 Highlights: MS Remyelination, AI Wearables, and Breakthroughs in Migraine and Alzheimer’s

In this special Curie episode, Matt covers the biggest clinical updates from the 2025 American Academy of Neurology Annual Meeting. Learn how CNM-Au8 is showing real signs of remyelination in MS, why AXS-05 may be the next approved treatment for Alzheimer’s agitation, and how Vyepti is delivering long-term migraine relief. We also spotlight Mi-Helper, a noninvasive cooling device for migraines, and the Felix NeuroAI wearable, a smart wristband reducing essential tremor through AI-guided stimulation. Tune in for expert quotes, clinical relevance, and cutting-edge neurology updates.

How measles found its way back

Measles is back—and it’s not just a public health story, it’s a political one. In this episode of Curie, we explore how the virus is spreading through undervaccinated communities and what the data tells us about the role of vaccine hesitancy. But we also look at what happens when the newly appointed HHS Secretary—Robert F. Kennedy Jr.—has a long record of casting doubt on vaccines. From CDC guideline influence to NIH funding cuts, this episode unpacks how political leadership may be reshaping vaccine confidence in real time.

The Overdiagnosis Dilemma

Is a diagnosis always the right answer? In this episode of Curie, we explore the growing debate around overdiagnosis, featuring neurologist Suzanne O’Sullivan’s provocative insights. As diagnostic rates for autism, ADHD, anxiety, and depression soar, we ask: Are we better at recognizing real struggles—or have we redrawn the line between normal and abnormal? This episode challenges assumptions, shares stories like that of 24-year-old Darcy, and invites healthcare professionals to reconsider the purpose—and the impact—of diagnostic labels.

System Overhaul: What HHS Layoffs Mean for the Future of U.S. Healthcare

In this episode, Matt dives into the largest restructuring in the history of the U.S. Department of Health and Human Services. With 10,000 staff laid off across the FDA, CDC, NIH, and beyond, what happens to the public health infrastructure clinicians rely on? Learn what’s changing, who it affects, and what HCPs should be watching closely.

The Tariff Prescription: How Pharma Trade Wars Could Redefine U.S. Healthcare

Love what you hear? Download the Curie app from the App Store today. Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Rising drug prices. Critical shortages. Vanishing innovation. In this in-depth episode of Curie, Matt investigates how proposed pharmaceutical tariffs could upend the U.S. healthcare system. With insights drawn from across the supply chain—generic manufacturers, biotech firms, and policy analysts—we explore how a trade policy decision might translate into real-world clinical disruption. If you're wondering how tariffs could affect prescribing decisions, drug access, or even your practice’s financial viability, this one’s essential listening.

From Equity to Optimization: How Politics Are Quietly Redefining Healthcare’s Future

Love what you hear? Download the Curie app from the App Store today. Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. As political pressures mount, key players in healthcare are shifting away from ‘equity’ toward ‘optimization.’ But what does this really mean for funding, research, and patient outcomes? In this episode of Curie, Matt investigates how Google, insurers, and hospitals are quietly rebranding their healthcare priorities—and why it matters for clinicians.

Fighting for Care: Doctors Speak Out on Insurance Delays

Love what you hear? Download the Curie app from the App Store today. Curie is your personalized, expert-driven healthcare podcast platform—offering in-depth analysis, timely insights, and discussions tailored for medical professionals. Prior authorizations, endless paperwork, and frustrating denials—healthcare professionals know this battle all too well. But how does this bureaucratic nightmare truly impact patient care? In this episode of Curie, Matt takes you beyond the statistics and into the real-world struggles of physicians navigating the insurance system. You'll hear directly from frontline HCPs who share their experiences with unnecessary delays, overturned denials, and the impact on both patients and providers. If you’ve ever fought to get your patients the care they need, this episode is for you.

5 of 8